{"id":"https://openalex.org/A5068529059","orcid":null,"observed_orcids":[],"display_name":"Terri Ridenour","raw_author_names":["Ridenour, Terri L.","T. Ridenour","Terri L. Ridenour","Terri Ridenour"],"full_name":"Ridenour, Terri L.","works_count":23,"cited_by_count":176,"summary_stats":{"2yr_mean_citedness":3.5,"h_index":6,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5068529059","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I111088046","ror":"https://ror.org/05qwgg493","display_name":"Boston University","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},"years":[2018]},{"institution":{"id":"https://openalex.org/I168537998","ror":"https://ror.org/01qat3289","display_name":"Eli Lilly (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},"years":[2023,2022,2021,2020,2019,2018,2017]},{"institution":{"id":"https://openalex.org/I189196454","ror":"https://ror.org/019kgqr73","display_name":"The University of Texas at Arlington","country_code":"US","type":"education","lineage":["https://openalex.org/I189196454"]},"years":[2019]},{"institution":{"id":"https://openalex.org/I27837315","ror":"https://ror.org/00jmfr291","display_name":"University of Michigan","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},"years":[2026,2025]},{"institution":{"id":"https://openalex.org/I4405258921","ror":"https://ror.org/01df9hd73","display_name":"Institute for Social Research","country_code":"US","type":"other","lineage":["https://openalex.org/I27837315","https://openalex.org/I4405258921"]},"years":[2025]},{"institution":{"id":"https://openalex.org/I58956616","ror":"https://ror.org/051fd9666","display_name":"Case Western Reserve University","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]},"years":[2019]},{"institution":{"id":"https://openalex.org/I83399316","ror":"https://ror.org/0420db125","display_name":"Rockefeller University","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]},"years":[2018]},{"institution":{"id":"https://openalex.org/I98704320","ror":"https://ror.org/04a9tmd77","display_name":"Icahn School of Medicine at Mount Sinai","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]},"years":[2018]}],"last_known_institutions":[{"id":"https://openalex.org/I27837315","ror":"https://ror.org/00jmfr291","display_name":"University of Michigan","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","count":21,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","count":18,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","count":12,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":5,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","count":4,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","value":0.0001069,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","value":9.75e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","value":3.74e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","value":2.73e-05,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":1.32e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","score":0.9962910413742065},{"id":"2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","score":0.9924993515014648},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9751225709915161},{"id":"2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","score":0.8619954586029053},{"id":"2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","score":0.8036412000656128}],"counts_by_year":[{"year":2017,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2018,"works_count":2,"oa_works_count":1,"cited_by_count":4},{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":8},{"year":2020,"works_count":3,"oa_works_count":1,"cited_by_count":12},{"year":2021,"works_count":9,"oa_works_count":5,"cited_by_count":9},{"year":2022,"works_count":4,"oa_works_count":3,"cited_by_count":29},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":34},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":31},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":26},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":21}],"display_name_alternatives":["Ridenour, Terri L.","T. Ridenour","Terri L. Ridenour","Terri Ridenour"],"block_key":"t ridenour","works_api_url":"https://api.openalex.org/works?filter=author.id:A5068529059","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5068529059","updated_date":"2026-11-12T13:17:38","created_date":"2017-11-10T00:00:00"}